Duke University School of Medicine receives FDA approval of a stem cell product, called DUCORD, for patients with disorders affecting the body’s blood production system. They are currently conducting research into using cord blood stem cells to help heal a brain damaged by hydrocephalus. The research is being led by Dr. Joanne Kurtzberg, chief of the Division of Pediatric Blood and Marrow Transplantation at Duke. Dr. Kurtzberg hopes that this initial approval will allow for future approval for the use of cord blood stem cells into the treatment of hydrocephalus.
Duke Medical Schools Receives FDA Approval for Stem Cell Product
4 Comments for : Duke Medical Schools Receives FDA Approval for Stem Cell Product